INSIGHTS ON DRUG DEVELOPMENT

• Development Of Separation Methods for GLP-1 Synthetic Peptides

  Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.

• Time To Intensify: Taking mAb Manufacturing To The Next Level

  Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.

• Unlocking The Future: Exploring Cutting-Edge Cell And Gene Therapies

  Explore the transformative potential of cutting-edge cell and gene therapies, focusing on CAR-T cell therapy, CRISPR-Cas9 gene editing, and other advanced approaches.

• Getting Genomic Medicines Ready For Prime Time

  Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.

• Rapid Automated Selection Of Mammalian Cell Colonies

  3/17/2025

  Discover how a new technology cultivates mammalian cells into clonal colonies and images them using fluorescent assays to isolate clonal cell populations based on surface protein expression.

• Cost And Scalability Key Drivers Of Expanded Gene Therapy Access

  5/16/2025

  Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

• Overcoming Excipient Risks And Challenges For Parenteral Formulations

  8/27/2025

  Excipients are essential to parenteral formulations, which help protect APIs, enhance stability, and ensure safety. Learn how strategic excipient selection can optimize drug performance and patient outcomes.

• How A Privately Owned CDMO Is Transforming Client Expectations

  5/16/2024

  Finding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.

• Understanding Biotherapeutic Peptides And GLP-1 Receptor Agonists

  9/2/2025

  Biotherapeutic peptides offer enhanced safety and efficacy over traditional drugs. Learn why rigorous impurity profiling is vital to ensure product quality, patient safety, and regulatory compliance.